Search


	Podcast:		OncLive® On Air
	Episode:		28: Markman and Monk Provide Perspective on the Utility of PARP Inhibitors in Ovarian Cancer
	Category:		Science & Medicine
	Duration:		00:19:11
	Publish Date:		2020-08-10 13:36:38
	Description:		In our exclusive interview, Bradley J. Monk, MD, FACS, FACOG, and Maurie Markman, MD, discuss the rationale behind maintenance therapy, pivotal PARP inhibitor trials in the frontline setting, and the importance of shared-decision making.
	Total Play:		0